New systems. New partnerships. A new operating category.Follow how Jumo Health is making patient readiness measurable and executable.Every announcement connects to one outcome: more predictable completion.
Two announcements mark the transition from readiness as an idea to readiness as an operating system.
The partnership strengthens PRISM™ with advanced conversational, generative, and agentic AI delivery capabilities designed for governed real-world study execution.
Read the Release →Official Jumo Health announcements, published locally in full.
Partnership strengthens patent-pending PRISM with advanced AI delivery capabilities for real-world study execution.
Read the Release →PRISM reframes trial execution by treating patient readiness as a primary driver of completion and predictability.
Read the Release →For interviews, company information, product background, or commentary on patient readiness and clinical trial execution.
Executive spokespeople are available for conversations about readiness, behavioral science, AI, patient experience, and completion-focused trial execution.
Jumo Health launched PRISM, its Patient Readiness and Intelligence System, and announced a strategic partnership with Areti Health to strengthen its governed AI delivery capabilities.
PRISM is a readiness-based clinical trial execution system designed to identify eligible patients, assess readiness, govern advancement, and protect participation through completion.
Send media and analyst inquiries to readiness@jumohealth.com.
Current official releases are published on this News page and linked directly from the release archive above.
In two days, you get three execution diagnostics on your program.
How likely each eligible patient cluster is to activate, persist, and complete, before any intervention.
The barriers most likely to suppress activation, enrollment, and completion in each cluster, and how to mitigate them.
Which clusters to target, which barriers to address, which interventions to deploy, and what completion lift to expect.